$80MSeries A, 18 March 2026
Funds health system expansion, platform development and team growth
- Amount
- $80M
- Stage
- Series A
- Announced
- 18 March 2026
- Lead
- Spark Capital
- Other investors
- Transformation Capital, Conviction, McKesson Ventures, General Catalyst, Y Combinator
- Use of funds
- Funds health system expansion, platform development and team growth
- Checked
- Matched to an official SEC filing
- Sources
- Latent raises $80M Series A for AI medication approval platform businesswire.com
Latent raises $80M Series A for AI medication approval platform pulse2.com